Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS Patients

NCT06802328 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Non-Active Secondary Progressive Multiple Sclerosis

Interventions

DRUG: Foralumab TZLS-401 50 µg

Sponsor

Tiziana Life Sciences LTD